Research has employed IgM antibodies produced from B-2 cells to evaluate ... more
Research has employed IgM antibodies produced from B-2 cells to evaluate the pathologic assessment of antibody-mediated rejection (AMR) in transplant recipients. However, there may be some difficulties in producing monoclonal IgM antibodies from B-2 cells.
For more: https://non-igg-ab.creative-biolabs.com/b-2-cells-that-produce-igm-antibodies.htm